Sun Pharma gains on US launch of Leqselvi, analysts see strong upside
Ram Prasad Sahu
Listen to This Article
India's largest drug maker, Sun Pharmaceutical Industries (Sun), gained 2.7 per cent on Tuesday and was the highest gainer among Sensex stocks. The gains followed the company's settlement and licence agreement with Incyte Corporation regarding litigation over its hair-loss drug, Leqselvi (Deuruxolitinib). Sun has now launched the specialty product in the US market.
The settlement grants Sun a limited, non-exclusive licence to US patents covering the drug for non-oncology indications. This includes alopecia areata, an auto-immune disease that causes hair loss.
While financial terms have not been disclosed, Sun will make an upfront payment and ongoing royalties to Incyte in

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
17 hours ago
- Economic Times
HDFC Bank Q1 Results: PAT rises 12% YoY to Rs 18,155 crore; dividend of Rs 5 per share declared
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price


Economic Times
17 hours ago
- Economic Times
Oriental Hotels reports Q1 standalone net profit at Rs 8.71 crore
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Economic Times
17 hours ago
- Economic Times
Nifty ends 3rd straight week in red, bearish momentum strengthens below 20 DEMA: Sudeep Shah
Markets continued their downward trend for a third straight week, as investors remained cautious amid a weak start to the earnings season and persistent uncertainty over the US-India trade agreement. ADVERTISEMENT Like the previous week, the benchmark indices displayed some resilience during the first three sessions, but sentiment turned negative in the latter half. Consequently, both the Nifty and Sensex closed near their weekly lows at 24,968.40 and 81,757.73, respectively. Analyst Sudeep Shah, Deputy Vice President and Head of Technical & Derivatives Research, SBI Securities, interacted with ET Markets regarding the outlook on Nifty and Bank Nifty for the upcoming week. Here are the edited excerpts from his chat: The benchmark index Nifty ended in the red for the third consecutive week, reflecting sustained bearish sentiment in the market. On the weekly chart, it has formed a bearish candle with a lower high and lower low structure — a classic indication of downward momentum. Throughout the week, the index attempted three times to reclaim its 20-day EMA but was rejected on each occasion. It is now trading decisively below the 20-day EMA, which has started to edge lower, further reinforcing the bearish the upward slope of the 50-day and 100-day EMAs has begun to flatten, signalling a potential loss of medium-term momentum. This slowdown in the EMA slope suggests growing indecisiveness and weakening strength among bulls. On the momentum front, the daily RSI is quoting at 43, marking its lowest level since April 2025. Moreover, the RSI is trading below its 9-day average, and both are in falling mode, indicating weakening internal strength and reinforcing the ongoing bearish setup. ADVERTISEMENT Going ahead, Monday's trading session will be crucial for the index as heavyweights like Reliance Industries, HDFC Bank, and ICICI Bank are set to announce their Q1 results over the weekend. The reaction to these earnings could provide near-term direction and either amplify the current trend or spark a crucial levels, the zone of 24940-24900 will act as immediate support for the index, as it is the confluence of the 50-day EMA level and the 61.8% Fibonacci retracement level of its prior upward rally (24473-25669). If the index slips below the 24,900 level, then the next crucial support is placed at the 24,700 level. On the upside, the zone of 25,130-25,160 will act as an immediate hurdle for the index. ADVERTISEMENT Yes, one of the key developments to watch is the ongoing tariff-related discussions between India and the US. Any escalation or resolution in these talks could have a direct impact on trade dynamics, especially in sectors like pharmaceuticals, IT services, and industrial goods. ADVERTISEMENT The banking benchmark index, Bank Nifty, also extended its losing streak, ending in the red for the third consecutive week. On the daily chart, it witnessed a breakdown from a Rising Wedge pattern on Friday and also slipped below its 20-day EMA, which is a sign of growing bearish pressure.A key technical observation lies in the daily RSI behaviour. Despite a mid-week pullback, the daily RSI failed to surpass the 60 level, which is a bearish sign as per RSI range shift rules. Currently, the RSI is quoting at 45, its lowest level since March 2025, indicating a notable loss of momentum and growing weakness in the ahead, the 50-day EMA zone of 55,950-55,850 will act as immediate support for the index. If the index slips below the 55,850 level, then the next crucial support is placed at the 55300 level. On the upside, the 20-day EMA zone of 56,700-56,800 will act as an important hurdle for the index. ADVERTISEMENT In the cash segment, FIIs have offloaded equities worth nearly 17,000 crores so far this month, indicating persistent selling pressure. Simultaneously, in the derivatives segment, the FII long-short ratio has slipped to just 15%, the lowest in the recent period. This reflects an aggressive build-up of short positions and a cautious near-term outlook from institutional it's worth noting that historically, whenever the FII long-short ratio drops below the 15% mark, markets often witness a limited downside, as excessive pessimism tends to set the stage for short-covering rallies or a reversal in sentiment. While the current data suggests a bearish stance by FIIs, the extremely low long-short ratio also indicates that much of the negativity may already be priced in, leaving room for a potential bounce if a positive trigger emerges. Technically, Dalmia Bharat, Godrej Properties, Bajaj Finance, Chennai Petro, and Sumitomo Chemical are likely to continue their outperformance. Technically, BDL, HAL, and Shiriram Finance are looking good from a short-sell the short term, both stocks are bearish as they are quoting below their 20-day EMA level. The RSI of Axis Bank is quoting below 40, which is a bearish sign. Further, the Reliance daily RSI is quoting below its 9-day average. Currently, the major trend for both HDFC Bank and ICICI Bank remains sideways, reflecting a lack of strong directional bias. On the technical front, the daily RSI for both stocks is oscillating in the 40–60 range, indicating a phase of consolidation and indecisiveness among traders. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)